RCM
ROSG

Rotella Capital Management’s Rosetta Genomics Ltd. ROSG Stock Holding History

Rotella Capital Management’s Portfolio ROSG Stock Details ROSG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-1,245
Closed -$37K – 664
2015
Q3 		$37K Sell
1,245
-422
-25% -$14.4K 0.01% 506
2015
Q2 		$68K Buy
+1,667
New +$71.3K 0.06% 337

Other funds holding ROSG

HCM
Highlander Capital Management Short Hills, New Jersey $292M AUM 22.24% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
ICAS
Investors Capital Advisory Services Lynnfield, Massachusetts $521M AUM 1.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Rotella Capital Management's ROSG Position: Q4 2015 in Review

Rotella Capital Management sold out of Rosetta Genomics Ltd. (ROSG) in Q4 2015, closing a stake of 1,245 shares — an estimated $37K sold.

Rotella Capital Management first reported a position in ROSG in Q2 2015 and held it in 2 quarters. The position peaked at $68K in Q2 2015. 11 funds tracked by Wall St. Rank hold ROSG as of Q4 2015.

  • Rotella Capital Management reported no remaining Rosetta Genomics Ltd. position as of Q4 2015 after selling out during the quarter.
  • Rotella Capital Management sold 1,245 Rosetta Genomics Ltd. shares in Q4 2015, an estimated $37K.
  • Rotella Capital Management first reported a position in Rosetta Genomics Ltd. in Q2 2015 and held it in 2 quarters.
  • Rotella Capital Management's Rosetta Genomics Ltd. position peaked at $68K in Q2 2015.
  • 11 funds tracked by Wall St. Rank held Rosetta Genomics Ltd. as of Q4 2015.

Based on Rotella Capital Management's 13F filing for Q4 2015, filed 9 Feb 2016.